Armata Pharmaceuticals Inc. sell Lokrim
Start price
09.07.23
/
20%
€1.02
Target price
09.07.24
-
Performance (%)
123.53%
End price
11.12.23
€2.28
Summary
This prediction ended on 11.12.23 with a price of €2.28. The SELL prediction by Lokrim for Armata Pharmaceuticals Inc. was trending in the completely wrong direction and closed with a performance of 123.53%. Lokrim has a follow-up prediction for Armata Pharmaceuticals Inc. where he still thinks Armata Pharmaceuticals Inc. is a Sell. Lokrim has 20% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Armata Pharmaceuticals Inc. | 2.000% | 2.000% | -19.048% |
| iShares Core DAX® | -1.114% | 5.062% | 24.922% |
| iShares Nasdaq 100 | 1.816% | 9.828% | 29.548% |
| iShares Nikkei 225® | 2.113% | 8.218% | 22.231% |
| iShares S&P 500 | 2.038% | 7.448% | 30.358% |
According to Lokrim what are the pros and cons of Armata Pharmaceuticals Inc. for the foreseeable future?
Pros
Cons
Revenue decline/stagnation expected
Risky Investment
Comments by Lokrim for this prediction
In the thread Armata Pharmaceuticals Inc. diskutieren
Sell Armata Pharmaceuticals Inc.
In the thread Trading Armata Pharmaceuticals Inc.
Current prediction by Lokrim for Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€2.22
17.08.24
17.08.24
-
17.08.25
17.08.25
-8.11%
04.10.24
04.10.24
Revenue decline/stagnation expected
Risky Investment
